Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients
NCT01697969
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergic Conjunctivitis
Interventions
DRUG:
Olopatadine hydrochloride ophthalmic solution, 0.2%
Sponsor
Alcon Research